167 related articles for article (PubMed ID: 6761009)
1. Intensive chemotherapy for solid tumours--current clinical applications.
Kaye SB
Cancer Chemother Pharmacol; 1982; 9(3):127-33. PubMed ID: 6761009
[TBL] [Abstract][Full Text] [Related]
2. Perspectives for the use of high-dose chemotherapy in the treatment of solid malignant tumors.
Sculier JP; Klastersky J
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1335-7. PubMed ID: 6389145
[No Abstract] [Full Text] [Related]
3. High-dose thiotepa alone and in combination regimens with bone marrow support.
Antman K; Eder JP; Elias A; Ayash L; Shea TC; Weissman L; Critchlow J; Schryber SM; Begg C; Teicher BA
Semin Oncol; 1990 Feb; 17(1 Suppl 3):33-8. PubMed ID: 2106166
[TBL] [Abstract][Full Text] [Related]
4. High-dose etoposide and marrow transplantation.
Herzig RH
Cancer; 1991 Jan; 67(1 Suppl):292-8. PubMed ID: 1984830
[TBL] [Abstract][Full Text] [Related]
5. High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors.
Mulder PO; Sleijfer DT; Willemse PH; de Vries EG; Uges DR; Mulder NH
Cancer Res; 1989 Aug; 49(16):4654-8. PubMed ID: 2545349
[TBL] [Abstract][Full Text] [Related]
6. High-dose combination chemotherapy with autologous bone marrow transplantation in adult solid tumors.
Spitzer G; Dicke KA; Litam J; Verma DS; Zander A; Lanzotti V; Valdivieso M; McCredie KB; Samuels ML
Cancer; 1980 Jun; 45(12):3075-85. PubMed ID: 6992970
[TBL] [Abstract][Full Text] [Related]
7. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
8. High-dose combination alkylating agents with autologous bone marrow support: a Phase 1 trial.
Peters WP; Eder JP; Henner WD; Schryber S; Wilmore D; Finberg R; Schoenfeld D; Bast R; Gargone B; Antman K
J Clin Oncol; 1986 May; 4(5):646-54. PubMed ID: 3517240
[TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy regimens for solid tumors.
van der Wall E; Beijnen JH; Rodenhuis S
Cancer Treat Rev; 1995 Mar; 21(2):105-32. PubMed ID: 7758003
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors-A pediatric blood and marrow transplant consortium study.
Ozkaynak MF; Sahdev I; Gross TG; Levine JE; Cheerva AC; Richards MK; Rozans MK; Shaw PJ; Kadota RP
J Pediatr Hematol Oncol; 2008 Mar; 30(3):204-9. PubMed ID: 18376282
[TBL] [Abstract][Full Text] [Related]
11. Relevance of high-dose chemotherapy in solid tumours.
Nieboer P; de Vries EG; Mulder NH; van der Graaf WT
Cancer Treat Rev; 2005 May; 31(3):210-25. PubMed ID: 15944050
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study.
Lazarus HM; Gray R; Ciobanu N; Winter J; Weiner RS
Bone Marrow Transplant; 1994 Sep; 14(3):443-8. PubMed ID: 7994270
[TBL] [Abstract][Full Text] [Related]
13. Carmustine, Ara C, cyclophosphamide and etoposide with autologous bone marrow transplantation in relapsed or refractory lymphoma: a dose-finding study.
Snyder MJ; Johnson DB; Daly MB; Giguere JK; Harman GH; Harden EA; Johnson RA; Leff RS; Mercier RJ; Messerschmidt GL
Bone Marrow Transplant; 1994 Oct; 14(4):595-600. PubMed ID: 7858534
[TBL] [Abstract][Full Text] [Related]
14. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
[TBL] [Abstract][Full Text] [Related]
15. High-dose hydroxyurea in autologous bone marrow transplantation: a promising "new" agent.
Vaughan WP; Bierman PJ; Reed EC; Glenn LD; Kessinger A; Armitage JO
Semin Oncol; 1992 Jun; 19(3 Suppl 9):110-5. PubMed ID: 1641652
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of granulocyte-macrophage colony-stimulating factor plus high-dose cyclophosphamide given every 2 weeks: a Cancer and Leukemia Group B study.
Lichtman SM; Ratain MJ; Van Echo DA; Rosner G; Egorin MJ; Budman DR; Vogelzang NJ; Norton L; Schilsky RL
J Natl Cancer Inst; 1993 Aug; 85(16):1319-26. PubMed ID: 8340944
[TBL] [Abstract][Full Text] [Related]
17. Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors.
Ozkaynak MF; Matthay K; Cairo M; Harris RE; Feig S; Reynolds CP; Buckley J; Villablanca JG; Seeger RC
J Clin Oncol; 1998 Mar; 16(3):937-44. PubMed ID: 9508176
[TBL] [Abstract][Full Text] [Related]
18. Phase I trial of dacarbazine with cyclophosphamide, carmustine, etoposide, and autologous stem-cell transplantation in patients with lymphoma and multiple myeloma.
Adkins DR; Salzman D; Boldt D; Kuhn J; Irvin R; Roodman GD; Lyons R; Smith L; Freytes CO; LeMaistre CF
J Clin Oncol; 1994 Sep; 12(9):1890-901. PubMed ID: 7916039
[TBL] [Abstract][Full Text] [Related]
19. [Late intensive chemotherapy with bone marrow autograft. Pilot study in small cell bronchial cancer].
Sculier JP; Klastersky J; Stryckmans P
Presse Med; 1983 Mar; 12(11):677-80. PubMed ID: 6300826
[TBL] [Abstract][Full Text] [Related]
20. High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experience.
Antman K; Eder JP; Elias A; Shea T; Peters WP; Andersen J; Schryber S; Henner WD; Finberg R; Wilmore D
Cancer Treat Rep; 1987 Feb; 71(2):119-25. PubMed ID: 3542208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
